Expanding PET Radiopharmaceutical Production in India: IBA and Shreeji’s Strategic Partnership

In a significant move to enhance PET radiopharmaceutical manufacturing in India, IBA (Ion Beam Applications S.A.) and Shreeji Imaging and Diagnostic Centre Pvt. Ltd. have entered into a multi-site agreement. This collaboration involves the delivery and installation of four state-of-the-art Cyclone KIUBE 300 cyclotrons, which will be strategically positioned in Ahmedabad, Nagpur, Kochi, and Bhubaneswar. With a contract value estimated between €5-7 million, this initiative aims to bolster the production of fluorine-18 (F-18) labelled compounds and other essential PET radiopharmaceuticals.

Expanding PET Radiopharmaceutical Production in India: IBA and Shreeji's Strategic Partnership

The Growing Demand for PET Imaging

India’s PET imaging market is experiencing rapid growth, driven by an increasing need for accessible medical imaging beyond metropolitan areas. As healthcare facilities expand into smaller cities, the demand for secure and reliable tracer supply intensifies. Shreeji’s investment in four new Cyclone KIUBE cyclotrons directly addresses this demand, ensuring that high-quality F-18 production is more accessible to patients while minimizing logistical challenges.

Enhancing Manufacturing Capabilities

The addition of these cyclotrons to Shreeji’s existing manufacturing network will not only improve the availability of PET radiopharmaceuticals but also create additional capacity for new tracers. This strategic expansion fortifies IBA’s presence in India and aligns with its mission to provide timely and reliable access to PET diagnostics, especially in the field of cancer care. The focus is on building a durable infrastructure that supports long-term service and future upgrades.

High-Performance Technology

Shreeji opted for the Cyclone KIUBE due to its impressive beam current capability, industrial reliability, and a defined upgrade path that allows for flexible production as tracer portfolios evolve. The platform is designed to maintain compliance with Good Manufacturing Practices (GMP), ensuring a steady supply of F-18 while keeping operating costs manageable across multiple locations.

Commitment to Societal Impact

Charles Kumps, President of IBA RadioPharma Solutions, emphasized the company’s dedication to fostering positive societal impacts globally. He noted that as India’s nuclear medicine community expands, establishing reliable local manufacturing is crucial for enhancing patient access. Partnering with Shreeji to deploy a network of Cyclone KIUBE systems represents a significant step toward achieving sustainable growth in PET imaging and improving supply consistency for medical professionals and patients alike.

Strengthening Supply Chain Resilience

Amit Maniar, Director of Shreeji, highlighted the transformative potential of the new systems. The deployment of four additional cyclotrons will significantly enhance domestic production capabilities, fortifying supply-chain resilience. This expansion positions Shreeji to introduce next-generation tracers that will elevate patient care standards. By ensuring cost-effective access to a broad spectrum of F-18 isotopes and novel isotopes, Shreeji anticipates stimulating latent demand in the PET market.

Preparing for Future Healthcare Growth

This strategic partnership not only addresses current needs but also prepares the ground for future healthcare developments across emerging hubs in India. The increased production capacity will contribute to a robust network, ensuring consistent and dependable service nationwide. With improved redundancy in operations, the collaboration aims to enhance the overall healthcare landscape.

Conclusion

The agreement between IBA and Shreeji marks a pivotal moment for PET radiopharmaceutical manufacturing in India. By investing in advanced cyclotron technology, both companies are poised to meet the growing demands of the healthcare sector while improving accessibility for patients. This collaboration not only reinforces local production capabilities but also sets a foundation for future innovations in medical imaging.

  • Key Takeaways
    • IBA and Shreeji partner to enhance PET radiopharmaceutical production in India.
    • Four new Cyclone KIUBE cyclotrons will be installed across four cities.
    • This expansion aims to improve access to F-18 compounds and bolster supply chain resilience.
    • The initiative aligns with the growing demand for PET imaging in smaller cities.
    • Commitment to sustainability and innovation positions Shreeji for future growth.

Read more → www.finanznachrichten.de